Company Quick10K Filing
Remedent
10-Q 2020-12-31 Filed 2021-02-16
10-Q 2020-09-30 Filed 2020-11-16
10-Q 2020-06-30 Filed 2020-08-14
10-K 2020-03-31 Filed 2020-06-29
10-Q 2019-12-31 Filed 2020-02-14
10-Q 2019-09-30 Filed 2019-11-14
10-Q 2019-06-30 Filed 2019-08-14
10-K 2019-03-31 Filed 2019-06-28
10-Q 2018-12-31 Filed 2019-02-14
10-Q 2018-09-30 Filed 2018-11-14
10-Q 2018-06-30 Filed 2018-08-14
10-K 2018-03-31 Filed 2018-07-13
10-Q 2017-12-31 Filed 2018-02-14
10-Q 2017-09-30 Filed 2017-11-14
10-Q 2017-06-30 Filed 2017-08-14
10-K 2017-03-31 Filed 2017-06-29
10-Q 2016-12-31 Filed 2017-02-14
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-15
10-K 2016-03-31 Filed 2016-06-29
10-Q 2015-12-31 Filed 2016-02-16
10-Q 2015-09-30 Filed 2015-11-16
10-Q 2015-06-30 Filed 2015-08-14
10-K 2015-03-31 Filed 2015-06-29
10-Q 2014-12-31 Filed 2015-02-23
10-Q 2014-09-30 Filed 2014-11-19
10-Q 2014-06-30 Filed 2014-08-19
10-K 2014-03-31 Filed 2014-07-14
10-Q 2013-12-31 Filed 2014-02-14
10-Q 2013-09-30 Filed 2013-11-19
10-Q 2013-06-30 Filed 2013-08-14
10-K 2013-03-31 Filed 2013-07-15
10-Q 2012-06-30 Filed 2012-08-14
10-K 2012-03-31 Filed 2012-07-16
10-Q 2011-09-30 Filed 2011-11-21
10-Q 2011-06-30 Filed 2011-08-15
10-K 2011-03-31 Filed 2011-07-14
10-Q 2010-12-31 Filed 2011-02-14
10-Q 2010-09-30 Filed 2010-11-15
10-Q 2010-06-30 Filed 2010-08-16
10-K 2010-03-31 Filed 2010-07-13
10-Q 2009-12-31 Filed 2010-02-16

Remedent Financials

REMI Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash2,9763,2571,340204432513654624997753171219739920414816794107988614767895993765583678085
Accounts Receivable2,0922,3841,0918386356156189486437618831,1501,0629808198479551,0581,0099789329499249439499931,1021,1571,032996470234402443
Inventory2,2951,9981,0881,0781,0411,0741,061992959985975599593539503414397387402411401390362110116122125123115112111111111129
PP&E1,2641,1548806412,0892,1302,1622,2162,2402,2502,2792,1682,1842,2492,3392,4142,4492,4782,5132,5402,5672,5742,5742,5772,5782,5822,5822,5822,5822,6252,6322,6332,6332,393
Assets10,44310,6977,1426,9656,3386,3216,1836,5276,2156,0796,2856,1686,0045,8465,7065,5455,6455,6945,7415,7035,7135,7795,7924,7304,7144,9655,2645,4385,2805,2475,1267,8967,9337,927
Accounts Payable1,8311,5359911,0091,2029491,0719729591,0281,1125998187958038477436997577898698718481,0391,0631,2401,4531,5691,7001,7911,9081,9192,0022,110
Long-Term Debt1,2741,2911,3041,4531,4101,1601,2281,1311,1311,1311310
Liabilities7,4158,0475,7205,0605,3785,2785,6035,0404,6704,5384,6213,8503,6383,4653,3733,5123,3793,3943,4393,5203,4513,4853,4331,6211,5491,7291,9662,2072,1882,2342,3012,5042,6792,787
Stockholders' Equity1,9291,3023281,8889431,0265621,4691,5271,5231,6462,3192,3652,3812,3332,0322,2662,3002,3032,1832,2622,2942,3593,1083,1653,2363,2983,2313,0913,0132,8265,3925,1585,054
Income Statement ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue3,0023,3092,1021,2744154347245,9072,311767866261928916849985827692662588616610593537791679745485435346419404310242
Cost of Revenue8177963292852552603565,1051482542312173293013153972662001951571902061656093331982041831061171461197768
Gross Profit2,1852,5131,7739881601743688022,16351363544599615534588561492468431426403428-72458481541301329229274285233174
R&D11611748291118151624132418142522042408010200000000
SG&A1,8182,1891,8321,264807711795631434467555591532571391473311402450615374423418876425502539514461317471487278252
Tax861231060000000000013079251-8200-2000010010
Net Income537219-025-1228538104600685652-219-156-76-1882,551-166-160
Cash Flow ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating176831393-1,509-494-6177491-28224-552-255-18117457-189-43-53444-26121,639-34-2454-512259025-46
Cash Investing-49-34-2,498-1,259-20601-57564-71-5-16-21-25-28-166-266-4-92-21-80-9-10-0000
Cash Financing1,097-13871,5594021517-648-1-2071,558-231-94-24-912-1238-3812-1,0000